2019 – ESSA Pharma

Date	Title
May 16, 2019	Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics – Acquisition Expected to be Completed by Mid-Year 2019
May 10, 2019	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2019.
May 4, 2019	Preclinical Data Highlighting Therapeutic Potential of EPI-7386 Presented at 2019 American Urological Association Annual Meeting
April 17, 2019	ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting
March 28, 2019	ESSA Pharma Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2019
March 28, 2019	ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer
March 18, 2019	ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference
March 14, 2019	ESSA Pharma to Attend the 31st Annual ROTH Conference
February 11, 2019	ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium
February 7, 2019	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2018